ID   Hepa-1a 1/c/1
AC   CVCL_E4AR
SY   1/c/1
RX   PubMed=3431441;
RX   PubMed=6181572;
CC   Characteristics: Show significantly reduced levels of albumin production (PubMed=6181572).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E4AL ! Hepa-1a
SX   Female
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
RX   PubMed=3431441; DOI=10.1016/s0076-6879(87)51006-0;
RA   Darlington G.J.;
RT   "Liver cell lines.";
RL   Methods Enzymol. 151:19-38(1987).
//
RX   PubMed=6181572; DOI=10.1007/BF01538707;
RA   Darlington G.J., Papaconstantinou J., Sammons D.W., Brown P.C.,
RA   Wong E.Y., Esterman A.L., Kang J.;
RT   "Generation and chracterization of variants of mouse hepatoma cells
RT   with defects in hepato-specific gene expression. I. Albumin synthesis
RT   variants.";
RL   Somatic Cell Genet. 8:451-464(1982).
//